As of 2026-09-21, the Intrinsic Value of Praxis Precision Medicines Inc (PRAX) is -58.56 USD. This PRAX valuation is based on the model Peter Lynch Fair Value. With the current market price of 298.95 USD, the upside of Praxis Precision Medicines Inc is -119.59%.
Based on its market price of 298.95 USD and our intrinsic valuation, Praxis Precision Medicines Inc (PRAX) is overvalued by 119.59%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -58.56 - -58.56 | -58.56 | -119.59% |
| P/E | (279.92) - (343.16) | (313.30) | -204.8% |
| DDM - Stable | (86.02) - (231.27) | (158.64) | -153.1% |
| DDM - Multi | (36.13) - (76.37) | (49.14) | -116.4% |
| Market Cap (mil) | 8,334.73 |
| Beta | 4.07 |
| Outstanding shares (mil) | 27.88 |
| Enterprise Value (mil) | 7,859.97 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.04% |
| Cost of Debt | 5.00% |
| WACC | 7.36% |